Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors.
Guru Sonpavde
No relevant relationships to disclose
Joaquim Bellmunt
No relevant relationships to disclose
Jonathan E. Rosenberg
No relevant relationships to disclose
Dean F. Bajorin
No relevant relationships to disclose
Ashley Marie Regazzi
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Angela Q. Qu
No relevant relationships to disclose
Guenter Niegisch
No relevant relationships to disclose
Peter Albers
No relevant relationships to disclose
Andrea Necchi
No relevant relationships to disclose
Giuseppe di Lorenzo
No relevant relationships to disclose
Ronan Fougeray
Employment or Leadership Position - Pierre Fabre Medicament
Yu-Ning Wong
No relevant relationships to disclose
Srikala S. Sridhar
No relevant relationships to disclose
Yoo-Joung Ko
No relevant relationships to disclose
Matthew I. Milowsky
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose
Gregory Russell Pond
No relevant relationships to disclose